AYUSH-clean claim — ChatGPT Ads India glossary
The compliance bar every Ayurveda, Yoga, Unani, Siddha, and Homeopathy advertiser must clear before a conversational ad surface can carry their message.
Definition
In plain English, an AYUSH-clean claim is a wellness or treatment claim that never crosses into telling a prospective patient your product cures, prevents, or replaces medical treatment for a named disease. It talks about traditional use, general wellbeing, or symptom management instead of diagnosis and cure.
Technically, it is a claim that survives scrutiny under the Drugs and Magic Remedies (Objectionable Advertisements) Act 1954, the AYUSH ministry's advertising guidelines, and ASCI Chapter III, and that the advertiser can substantiate with documentation — clinical literature, traditional pharmacopoeia references, or manufacturer licensing — if a regulator or platform asks.
Why it matters for Indian healthcare marketers
India's AYUSH sector has grown into a serious paid-media category — wellness clinics, panchakarma centres, herbal pharma brands, and yoga-therapy platforms are all now bidding for attention on Google, Meta, and now ChatGPT Ads. But this is also the most heavily regulated corner of Indian health advertising, and enforcement has visibly tightened since 2023, with the Drugs and Magic Remedies Act being actively used against digital campaigns, not just print and TV.
The stakes for getting this wrong are not abstract. A disallowed claim can mean an ad account suspension, a legal notice under the Act, or — increasingly — a platform-side compliance flag that throttles delivery before a human ever reviews the account. For AYUSH brands specifically, the line between "supports digestive wellness" and "cures IBS" is the line between a running campaign and a shut-down one.
ChatGPT Ads raises the stakes further because the ad doesn't sit in a fixed creative slot — it's woven into a generated response. If your original claim language is aggressive, the model can restate it in its own words when a user asks a follow-up question, effectively laundering an overclaim into what reads like neutral AI output. Regulators and ASCI have not yet issued AYUSH-specific guidance for conversational ad surfaces, which means advertisers are operating in a genuine grey zone — and the safest position in a grey zone is always the more conservative claim, not the more permissive one.
There is also a commercial upside to getting this right early. AYUSH advertisers who build a documented claim-review process now are the ones who will survive the first wave of scrutiny when Indian regulators eventually catch up to conversational advertising — and they'll keep running campaigns while less careful competitors get paused.
How ICG uses/measures/handles it in a live engagement
Every AYUSH account inside ICG's ChatGPT Ads practice starts with a claim inventory: every product benefit statement, every headline, every conversational-response variant is logged and classified as cure-claim, wellness-claim, or traditional-use-claim before a single rupee is spent. Anything landing in the cure-claim bucket gets rewritten before launch — no exceptions, regardless of client pressure to keep punchier copy.
Substantiation is tracked alongside each claim, not as an afterthought. If a claim references traditional Ayurvedic use, we hold the pharmacopoeia citation on file. If it references a study, we hold the study. This isn't just a legal safety net — it becomes the raw material for FAQ-schema and citation-style landing page content, which conversational engines like ChatGPT tend to favour when selecting what to surface in a follow-up answer.
On the reporting side, we track a compliance flag rate alongside the usual conversation-completion metrics — impressions, conversation-stage bid movement, and the AI Assistant channel's key-event rate in GA4 (ICG's blended book runs at 10.49%, roughly double organic and 17x direct). A rising compliance-flag rate is treated as a leading indicator that copy needs another pass, not a lagging problem to fix after a suspension.
Re-review is scheduled quarterly for every AYUSH client, and immediately whenever AYUSH ministry guidance or ASCI rulings shift, because this is one of the few areas in Indian digital marketing where the compliance ground moves faster than the ad platforms do.
Related terms
Running AYUSH or wellness campaigns on ChatGPT Ads and need a compliance-first review?
Related specialty
Dental Clinics
Chair-count-aware conversational bidding for dental chains and solo practices.
Dermatology
Cosmetic + medical derm split campaigns with ASCI-safe claim language.
Cardiology
High-intent cardiac consult capture with NMC-clean claim language.
Compliance
NMC Section 6
Doctor and clinic promotion rules applied to AI-assistant placements.
DPDP Act 2023
Consent-flow and data-handling rules for conversational lead capture.
Frequently asked questions
What makes a claim AYUSH-clean for ChatGPT Ads?
A claim is AYUSH-clean when it describes traditional use, wellness support, or symptom relief in language that does not assert cure, prevention, or drug-equivalent efficacy for a named disease, and it is backed by documentation an advertiser can produce on request.
Why does this matter more for ChatGPT Ads than for search or display ads?
ChatGPT Ads surface inside a conversational answer where the model can restate or paraphrase your claim, so an aggressive claim risks being amplified in the AI's own words rather than sitting quietly in a banner a user can ignore.
Which law governs AYUSH claims in India?
The Drugs and Magic Remedies (Objectionable Advertisements) Act, AYUSH ministry advertising guidelines, and ASCI Chapter III jointly govern what an Ayurveda, Yoga, Unani, Siddha, or Homeopathy advertiser may claim in any paid medium, including conversational ad surfaces.
Does ICG write AYUSH-clean copy for ChatGPT Ads clients?
Yes. Every AYUSH client account under ICG's ChatGPT Ads practice goes through a claim review pass before launch and a recurring compliance re-check as campaigns scale.
